Diversity of potentially exploitable pharmacological activities of the highly prized edible medicinal fungus Antrodia camphorata.
Antrodia camphorata, also known as A. cinnamomea, is a precious medicinal basidiomycete fungus endemic to Taiwan. This article summarizes the recent advances in research on the multifarious pharmacological effects of A. camphorata. The mushroom exhibits anticancer activity toward a large variety of cancers including breast, cervical, ovarian, prostate, bladder, colorectal, pancreatic, liver, and lung cancers; melanoma; leukemia; lymphoma; neuroblastoma; and glioblastoma. Other activities encompass antiinflammatory, antiatopic dermatitis, anticachexia, immunoregulatory, antiobesity, antidiabetic, antihyperlipidemic, antiatherosclerotic, antihypertensive, antiplatelet, antioxidative, antiphotodamaging, hepatoprotective, renoprotective, neuroprotective, testis protecting, antiasthmatic, osteogenic, osteoprotective, antiviral, antibacterial, and wound healing activities. This review aims to provide a reference for further development and utilization of this highly prized mushroom.
['Wang|Caicheng|C|', 'Zhang|Weiwei|W|', 'Wong|Jack Ho|JH|', 'Ng|Tzibun|T|', 'Ye|Xiujuan|X|']
D055491:Antrodia D001688:Biological Products D014644:Genetic Variation D013624:Taiwan D013678:Technology, Pharmaceutical
Antrodia camphorata Anticancer Antiinflammatory Hepatoprotective Neuroprotective Antileukemia